Nerea Bitarte
Overview
Explore the profile of Nerea Bitarte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montes-Medina L, Hernandez-Fernandez A, Gutierrez-Rivera A, Ripalda-Cemborain P, Bitarte N, Perez-Lopez V, et al.
Injury
. 2018 Sep;
49(11):1979-1986.
PMID: 30219381
Acceleration of the consolidation of the distracted bone is a relevant medical need. As a platform to improve in vivo bone engineering, we developed a novel distraction osteogenesis (DO) model...
2.
Ruiz de Los Mozos I, Vergara-Irigaray M, Segura V, Villanueva M, Bitarte N, Saramago M, et al.
PLoS Genet
. 2013 Dec;
9(12):e1004001.
PMID: 24367275
The presence of regulatory sequences in the 3' untranslated region (3'-UTR) of eukaryotic mRNAs controlling RNA stability and translation efficiency is widely recognized. In contrast, the relevance of 3'-UTRs in...
3.
Abajo A, Bitarte N, Zarate R, Boni V, Lopez I, Gonzalez-Huarriz M, et al.
World J Gastroenterol
. 2012 Feb;
18(7):637-45.
PMID: 22363134
Aim: To investigate the angiogenesis-related protein expression profile characterizing metastatic colorectal cancer (mCRC) with the aim of identifying prognostic markers. Methods: The expression of 44 angiogenesis-secreted factors was measured by...
4.
Rodriguez J, Zarate R, Bandres E, Boni V, Hernandez A, Sola J, et al.
Eur J Cancer
. 2012 Feb;
48(12):1774-80.
PMID: 22305465
Background: The immunoglobulin G1 (IgG(1)) monoclonal antibody (MoAb) Cetuximab is active in metastatic colorectal cancer (mCRC) as first or subsequent lines of therapy. Efficacy seems restricted to KRAS wild-type tumours....
5.
Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M, et al.
Stem Cells
. 2011 Sep;
29(11):1661-71.
PMID: 21948564
Many antitumor therapies affect rapidly dividing cells. However, tumor proliferation may be driven by cancer stem cells (CSCs), which divide slowly and are relatively resistant to cytotoxic drugs. Thus, many...
6.
Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E, et al.
Mol Cancer Ther
. 2010 Jul;
9(8):2265-75.
PMID: 20647341
Thymidylate synthase (TYMS) is a target of the most widely used chemotherapeutic agents against gastrointestinal malignancies, the fluoropyrimidine-based therapy. TYMS expression levels have been identified as predictive biomarkers for 5-fluoruracil...
7.
Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, et al.
Int J Cancer
. 2009 Jun;
125(11):2737-43.
PMID: 19521961
In the last years, microRNAs (miRNA) have emerged as new molecular players involved in carcinogenesis. Deregulation of miRNAs expression has been shown in different human cancer but the molecular mechanism...
8.
Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, et al.
Clin Cancer Res
. 2009 Mar;
15(7):2281-90.
PMID: 19318487
Purpose: microRNAs (miRNA) are small RNAs that function as post-transcriptional regulators of gene expression. Recent evidence has shown that some miRNAs can act as oncogenes or tumor suppressors. This study...
9.
Bandres E, Zarate R, Ramirez N, Abajo A, Bitarte N, Gariia-Foncillas J
World J Gastroenterol
. 2007 Nov;
13(44):5888-901.
PMID: 17990354
Interindividual differences in the toxicity and response to anticancer therapies are currently observed in practically all available treatment regimens. A goal of cancer therapy is to predict patient response and...
10.
Bitarte N, Bandres E, Zarate R, Ramirez N, Garcia-Foncillas J
World J Gastroenterol
. 2007 Nov;
13(44):5813-21.
PMID: 17990347
Colorectal cancer is the third most common cancer and is highly fatal. During the last several years, research has been primarily based on the study of expression profiles using microarray...